Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Carbidopa and levodopa
Medication labelCarbidopa and levodopa extended-release tablets are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and…
Why this: Advisory · dailymed-prescription
Carbidopa and levodopa extended-release tablets are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
- generic_name
- carbidopa and levodopa
- product_names
- Carbidopa and Levodopa
- ndc
- 16729-078, 16729-079, 16729-079-10, 16729-079-01, 16729-079-16, 16729-079-17, 16729-078-10, 16729-078-01, 16729-078-16, 16729-078-17
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en